Effects of acute administration of nicotinic and muscarinic cholinergic agonists and antagonists on performance in different cost–benefit decision making tasks in rats
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Alterations in cost–benefit decision making accompany numerous neuropsychiatric conditions, including schizophrenia, attention deficit hyperactivity disorder, and addiction. Central cholinergic systems have been linked to the etiology and/or treatment of many of these conditions, but little is known about the role of cholinergic signaling in cost–benefit decision making. The goal of these experiments was to determine how cholinergic signaling is involved in cost–benefit decision making, using a behavioral pharmacological approach. Male Long-Evans rats were trained in either “probability discounting” or “delay discounting” tasks, in which rats made discrete-trial choices between a small food reward and a large food reward associated with either varying probabilities of omission or varying delays to delivery, respectively. The effects of acute administration of different doses of nicotinic and muscarinic acetylcholine receptor agonists and antagonists were assessed in each task. In the probability discounting task, acute nicotine administration (1.0 mg/kg) significantly increased choice of the large risky reward, and control experiments suggested that this was due to robust nicotine-induced impairments in behavioral flexibility. In the delay discounting task, the muscarinic antagonists scopolamine (0.03, 0.1, and 0.3 mg/kg) and atropine (0.3 mg/kg) both significantly increased choice of the small immediate reward. Neither mecamylamine nor oxotremorine produced reliable effects on either of the decision making tasks. These data suggest that cholinergic receptors play multiple roles in decision making contexts which include consideration of reward delay or probability. These roles should be considered when targeting these receptors for therapeutic purposes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Impulsivity and cigarette smoking: delay discounting in current, never, and ex-smokers
Bickel, W. K., Odum, A. L., & Madden, G. J. (1999) · Psychopharmacology · doi:10.1007/pl00005490 · Cited by 1,433
SUBJECTIVE PROBABILITY AND DELAY
Rachlin, H., Raineri, A., & Cross, D. (1991) · Journal of the Experimental Analysis of Behavior · doi:10.1901/jeab.1991.55-233 · Cited by 1,341
Measures of impulsivity in cigarette smokers and non-smokers
Mitchell, S. H. (1999) · Psychopharmacology · doi:10.1007/pl00005491 · Cited by 911
Nicotine amplifies reward-related dopamine signals in striatum
Rice, M. E., & Cragg, S. J. (2004) · Nature Neuroscience · doi:10.1038/nn1244 · Cited by 594 · cited 1×
“In addition, the fact that, like amphetamine, nicotine also induces release of catecholamines (including dopamine) suggests a possible shared mechanism for these effects (George et al. 2000; Rice and Cragg 2004).”
BackgroundField, M., Santarcangelo, M., Sumnall, H., Goudie, A., & Cole, J. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0385-4 · Cited by 250
Mukhin, A. G., Kimes, A. S., Chefer, S. I., Matochik, J. A., Contoreggi, C. S., Horti, A. G., Vaupel, D. B., Pavlova, O., & Stein, E. A. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.050716 · Cited by 135 · cited 2×
“…are poorly understood, despite the fact that cholinergic signaling plays an important role in the etiology and/or treatment of many neuropsychiatric disorders in which altered decision making is prominent (Mukhin et al. 2008; Potter and Newhouse 2005; Warpman and Nordberg 1995; Yip et al. 2009).”
BackgroundEffects of acute and chronic nicotine on impulsive choice in rats
Dallery, J., & Locey, M. L. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200502000-00002 · Cited by 113
Cited by
Dissecting impulsivity and its relationships to drug addictions
Jentsch, J. D., Ashenhurst, J. R., Cervantes, M. C., Groman, S. M., James, A. S., & Pennington, Z. T. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12388 · Cited by 281
Animal Models of Serotonergic Psychedelics
Hanks, J. B., & González-Maeso, J. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn300138m · Cited by 156
Nicotinic receptors in the ventral tegmental area promote uncertainty-seeking
Naudé, J., Tolu, S., Dongelmans, M., Torquet, N., Valverde, S., Rodriguez, G., Pons, S., Maskos, U., Mourot, A., Marti, F., et al. (2016) · Nature Neuroscience · doi:10.1038/nn.4223 · Cited by 61
Nicotinic alteration of decision-making
Naudé, J., Dongelmans, M., & Faure, P. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.11.021 · Cited by 39
“In rats, acute nicotine administration has been found to increase (Mendez et al., 2012) or decrease”
Silveira, M. M., Malcolm, E., Shoaib, M., & Winstanley, C. A. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.12.029 · Cited by 31
Metadata
- Authors
- Mendez, I. A., Gilbert, R. J., Bizon, J. L., & Setlow, B.
- Venue
- Psychopharmacology
- Published
- 2012-07-04
- Volume
- 224
- Issue
- 4
- Pages
- 489-499
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2004742241
- Cited by
- 57
- References
- 7
- FWCI
- 2.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of acute administration of nicotinic and muscarinic cholinergic agonists and antagonists on performance in different cost–benefit decision making tasks in rats. https://app.cochat.ai/papers/10.1007/s00213-012-2777-y
- The paper
- Mendez, I. A., Gilbert, R. J., Bizon, J. L., & Setlow, B. (2012). Effects of acute administration of nicotinic and muscarinic cholinergic agonists and antagonists on performance in different cost–benefit decision making tasks in rats. Psychopharmacology. https://doi.org/10.1007/s00213-012-2777-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.